PI3Kα-IN-9
CAS No. 2715287-67-3
PI3Kα-IN-9 ( —— )
产品货号. M35579 CAS No. 2715287-67-3
PI3Kα-IN-9 (compound 27) 是一种有选择性的口服长效 PI3Kα 抑制剂 (PI3Kα inhibitor),对于 PI3Kα、PI3Kγ、PI3Kδ 和 PI3Kβ,其 IC50 值分别为 4.4、128、146 和 153 nM。PI3Kα-IN-9 具有抗增殖活性并诱导细胞凋亡。PI3Kα-IN-9 可用于癌症研究。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥1169 | 有现货 |
|
| 10MG | ¥1881 | 有现货 |
|
| 25MG | ¥3692 | 有现货 |
|
| 50MG | ¥5385 | 有现货 |
|
| 100MG | ¥7092 | 有现货 |
|
| 500MG | ¥14310 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称PI3Kα-IN-9
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述PI3Kα-IN-9 (compound 27) 是一种有选择性的口服长效 PI3Kα 抑制剂 (PI3Kα inhibitor),对于 PI3Kα、PI3Kγ、PI3Kδ 和 PI3Kβ,其 IC50 值分别为 4.4、128、146 和 153 nM。PI3Kα-IN-9 具有抗增殖活性并诱导细胞凋亡。PI3Kα-IN-9 可用于癌症研究。
-
产品描述PI3Kα-IN-9 (compound 27) is a selective, long-acting and oral active PI3Kα inhibitor with IC50 values of 4.4, 128, 146 and 153 nM for PI3Kα, PI3Kγ, PI3Kδ and PI3Kβ, respectively. PI3Kα-IN-9 has antiproliferative activity and induces apoptosis. PI3Kα-IN-9 can be used for cancer research.
-
体外实验PI3Kα-IN-9 (compound 27) (0-8 μM; 72 hours; cancer cell lines) has antiproliferative activity and induces apoptosis.PI3Kα-IN-9 (compound 27) (0-8 μM; MGC-803 cells) down-regulates the expression of PI3Kα protein, the proteins of PI3K downstream, p-AKT and p-P70S6 K.Cell Viability Assay Cell Line:MGC-803 (gastric cancer), SKOV-3 (ovarian cancer), PC-3(prostate cancer), MCF-7 (breast cancer), MDA-MB-231 (triple-negative breast cancer), HepG2 (liver cancer), RPMI8226 (multiple myeloma), K562 (chronic myeloid leukemia), U251 (glioma) and MOLT-4 (acute lymphoblastic leukemia) cell lines Concentration:0-2 μM Incubation Time:72 hours Result:Inhibited the growth of a variety of cancer cells with IC50 values ranging from 0.43 to 1.33 μM.Apoptosis Analysis Cell Line:MGC-803 cells Concentration:0, 2, 4 and 8 μM Incubation Time:36 hours Result:Increased the percentage of apoptotic cells from 12.07 to 61.69% in a dose-dependent manner.
-
体内实验PI3Kα-IN-9 (compound 27) (1-10 mg/kg; p.o. and i.v.; for 24 hours; male Sprague-Dawley rat) has favorable stability (T1/2>10 h) and high bioavailability (130%).PI3Kα-IN-9 (compound 27) (30 mg/kg; p.o.; daily, for 3 weeks; male BALB/c nude mice) has antitumor activity and low cytotoxicity.Animal Model:Male Sprague-Dawley ratDosage:1 and 10 mg/kg Administration:Oral administration and intravenous injection.Animal Model:Male BALB/c nude mice Dosage:30 mg/kg Administration:Oral administration; daily, for 3 weeks Result:Inhibited tumor growth with a tumor growth inhibition (TGI) rate of 41.5%.
-
同义词——
-
通路Apoptosis
-
靶点Apoptosis
-
受体Apoptosis | PI3K
-
研究领域——
-
适应症——
化学信息
-
CAS Number2715287-67-3
-
分子量383.4
-
分子式C18H21N7O3
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO 中的溶解度 : 100 mg/mL (260.82 mM; 超声助溶 (<80°C)
-
SMILESN1=C(N=C(N=C1N2CCOCC2)N3CCOCC3)C4=CC=C5OC(=NC5=C4)N
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Hou Y, et, al. Discovery of Novel Phosphoinositide-3-Kinase α Inhibitors with High Selectivity, Excellent Bioavailability, and Long-Acting Efficacy for Gastric Cancer. J Med Chem. 2022 Jul 14.?
产品手册
关联产品
-
Mardepodect hydrochl...
Mardepodect hydrochloride (PF-2545920 hydrochloride) 是一种有效的,口服活性的,选择性的 PDE10A 抑制剂,IC50 为 0.37 nM,比作用于其他 PDE 选择性高 1000 多倍。Mardepodect hydrochloride 可穿过血脑屏障。
-
2-Deoxy-2-fluoro-bet...
2-Amino-9-((2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3,9-dihydro-6H-purin-6-one (9-β-D-[2'-Fluoro-2'-deoxy-arabinofuranosyl]-guanin) 是一种嘌呤核苷类似物。嘌呤核苷类似物具有广泛的抗肿瘤活性,靶向惰性淋巴系统恶性肿瘤。这一过程中的抗癌机制依赖于抑制 DNA 合成,诱导细胞凋亡 (apoptosis) 等。
-
LAT1-IN-1
LAT1-IN-1 (BCH) 显着抑制细胞对氨基酸的摄取和 mTOR 磷酸化,从而抑制癌症生长和细胞凋亡。
021-51111890
购物车()
sales@molnova.cn

